Advertisement
Advertisement

SLNO

SLNO logo

Soleno Therapeutics, Inc. Common Stock

52.95
USD
Sponsored
0.00
0.00%
May 08, 14:01 UTC -4
Closed
exchange

Pre-Market

52.71

-0.24
-0.45%

Soleno Therapeutics, Inc. Common Stock Profile

About

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Info & Links

CEO

Anish Bhatnagar

Headquarters

100 MARINE PARKWAY, SUITE 400
REDWOOD CITY, CA 94065, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.soleno.life

Auditor

Marcum llp

Share holders

31

Employees

182

Soleno Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.75B

Enterprise Value

2.66B

Enterprise Value/EBITDA(ttm)

30.10

Price to Earnings Ratio(ttm)

228.30

Price to Sales(ttm)

--

Price to Book(mrq)

6.27

Price to Cash(ytd)

122.93

Profitability

Gross Margin(ttm)

73.80%

Operating Margin(ttm)

--

Profit Margin(ttm)

17.95%

Return on Equity(ttm)

5.90%

Return on Invested Capital(ttm)

-3.69%

Return on Assets(ttm)

4.61%

Income Statement

Revenue(ttm)

285.01M

Revenue Per Share(ttm)

5.47

Gross Profit(ttm)

281.11M

EBITDA(ttm)3

88.50M

Net Income Available to Common(ttm)

95.63M

Diluted EPS(ttm)

0.23

Share Statistics

Beta (5Y Monthly)

-2.81

52-Week Change

-31.04%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

52.12M

Dividend Yield

0.00%

Float4

48.32M

% Held by Insiders

6.40%

% Held by Institutions

97.42%

Balance Sheet

Total Cash(mrq)

255.60M

Total Cash Per Share(mrq)

4.90

Total Debt(mrq)

49.87M

Total Debt/Equity(mrq)

11.08%

Current Ratio(mrq)

5.80%

Quick Ratio(mrq)

5.55%

Book Value Per Share(mrq)

8.61

Cash Flow

Operating Cash Flow Per Share(ytd)

0.89

Free Cash Flow(ytd)

46.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement